The Chemours Company (BMV:CC)
Mexico
· Delayed Price · Currency is MXN 298.87
+17.87 (6.36%)
At close: Feb 27, 2026
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 5,808 | 5,782 | 6,078 | 6,831 | 6,345 | Upgrade
|
| Revenue Growth (YoY) | 0.45% | -4.87% | -11.02% | 7.66% | 27.69% | Upgrade
|
| Cost of Revenue | 4,899 | 4,640 | 4,736 | 5,215 | 4,964 | Upgrade
|
| Gross Profit | 909 | 1,142 | 1,342 | 1,616 | 1,381 | Upgrade
|
| Selling, General & Admin | 504 | 595 | 1,286 | 705 | 583 | Upgrade
|
| Research & Development | 108 | 109 | 108 | 118 | 107 | Upgrade
|
| Operating Expenses | 612 | 704 | 1,394 | 823 | 690 | Upgrade
|
| Operating Income | 297 | 438 | -52 | 793 | 691 | Upgrade
|
| Interest Expense | -269 | -263 | -208 | -163 | -185 | Upgrade
|
| Earnings From Equity Investments | 35 | 43 | 45 | 55 | 43 | Upgrade
|
| Currency Exchange Gain (Loss) | -11 | -9 | -38 | -15 | 3 | Upgrade
|
| Other Non Operating Income (Expenses) | 19 | 11 | 19 | 57 | 36 | Upgrade
|
| EBT Excluding Unusual Items | 71 | 220 | -234 | 727 | 588 | Upgrade
|
| Merger & Restructuring Charges | -81 | -60 | -193 | -16 | -6 | Upgrade
|
| Impairment of Goodwill | - | -56 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 8 | 3 | 110 | 23 | 115 | Upgrade
|
| Legal Settlements | -270 | - | - | - | - | Upgrade
|
| Other Unusual Items | -5 | -1 | -1 | 7 | -21 | Upgrade
|
| Pretax Income | -277 | 106 | -318 | 741 | 676 | Upgrade
|
| Income Tax Expense | 109 | 37 | -66 | 163 | 68 | Upgrade
|
| Earnings From Continuing Operations | -386 | 69 | -252 | 578 | 608 | Upgrade
|
| Minority Interest in Earnings | - | - | -1 | - | - | Upgrade
|
| Net Income | -386 | 69 | -253 | 578 | 608 | Upgrade
|
| Net Income to Common | -386 | 69 | -253 | 578 | 608 | Upgrade
|
| Net Income Growth | - | - | - | -4.93% | 177.63% | Upgrade
|
| Shares Outstanding (Basic) | 150 | 149 | 149 | 155 | 165 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 150 | 149 | 158 | 169 | Upgrade
|
| Shares Change (YoY) | 0.04% | 0.85% | -5.93% | -6.16% | 1.41% | Upgrade
|
| EPS (Basic) | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 | Upgrade
|
| EPS (Diluted) | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 | Upgrade
|
| EPS Growth | - | - | - | 1.39% | 172.73% | Upgrade
|
| Free Cash Flow | 51 | -993 | 186 | 448 | 537 | Upgrade
|
| Free Cash Flow Per Share | 0.34 | -6.61 | 1.25 | 2.83 | 3.18 | Upgrade
|
| Dividend Per Share | 0.512 | 1.000 | 1.000 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | -48.75% | - | - | - | - | Upgrade
|
| Gross Margin | 15.65% | 19.75% | 22.08% | 23.66% | 21.77% | Upgrade
|
| Operating Margin | 5.11% | 7.58% | -0.86% | 11.61% | 10.89% | Upgrade
|
| Profit Margin | -6.65% | 1.19% | -4.16% | 8.46% | 9.58% | Upgrade
|
| Free Cash Flow Margin | 0.88% | -17.17% | 3.06% | 6.56% | 8.46% | Upgrade
|
| EBITDA | 637 | 730 | 257 | 1,084 | 1,008 | Upgrade
|
| EBITDA Margin | 10.97% | 12.63% | 4.23% | 15.87% | 15.89% | Upgrade
|
| D&A For EBITDA | 340 | 292 | 309 | 291 | 317 | Upgrade
|
| EBIT | 297 | 438 | -52 | 793 | 691 | Upgrade
|
| EBIT Margin | 5.11% | 7.58% | -0.85% | 11.61% | 10.89% | Upgrade
|
| Effective Tax Rate | - | 34.91% | - | 22.00% | 10.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.